Parallax Volatility Advisers »

Arcutis Biotherapeutics shares owned by Parallax Volatility Advisers

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Parallax Volatility Advisers from 13F filings

Historical chart of Parallax Volatility Advisers investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Parallax Volatility Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Parallax Volatility Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $889k 275k 3.23
2023-09-30 $1.6M 299k 5.31
2023-06-30 $2.5M 264k 9.53
2023-03-31 $5.2M 476k 11.00
2022-12-31 $2.5M 166k 14.80

More positions owned by Parallax Volatility Advisers

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Call Option (META)
NVIDIA Corporation (NVDA)
Tesla Motors Call Option (TSLA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr Gold Tr Gold Shs Put Option (GLD)
Select Sector Spdr Tr Energy (XLE)
Pdd Holdings Sponsored Ads Put Option (PDD)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Palo Alto Networks (PANW)
Amazon (AMZN)
Royal Caribbean Cruises Put Option (RCL)

View all positions for Parallax Volatility Advisers

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Vanguard Group
Franklin Resources
Millennium Management
Opaleye Management
Jennifer Ranahan
Deutsche Bank Aktiengesellschaft
Tejara Capital
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Federated Investors
AMI Asset Management Corporation
Walleye Trading Advisors

View all funds holding Arcutis Biotherapeutics